H. Sörensen

4.0k citations

25 papers · 2.9k indexed · 1 hit paper · h-index 17

Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies 16
- Spondyloarthritis Studies and Treatments 14
- Dupuytren's Contracture and Treatments 2
Hematology top 1%
- Autoimmune and Inflammatory Disorders Research 5
Immunology top 2%
- Psoriasis: Treatment and Pathogenesis 3
Orthopedics and Sports Medicine top 5%
Genetics top 10%
- Chronic Lymphocytic Leukemia Research 2
Pulmonary and Respiratory Medicine
- Respiratory and Cough-Related Research 2
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 2

Co-authors: Joachim Sieper Joachim Listing J. Brandt Jürgen Braun H. Kellner Rieke Alten A. Zink H. Zeidler
Cited by: Rheumatology Hematology Immunology
Journals: The Lancet (1 paper)Journal of the American Geriatrics Society (1 paper)Annals of the Rheumatic Diseases (2 papers)
Partner nations: Germany Denmark United States

In The Last Decade

H. Sörensen

25 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by H. Sörensen

Since Specialization

Citations

This map shows the geographic impact of H. Sörensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Sörensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Sörensen more than expected).

Fields of papers citing papers by H. Sörensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Sörensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Sörensen. The network helps show where H. Sörensen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H. Sörensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Sörensen Line = papers co-authored together H. Sörensen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Using a Patient-Reported Outcome Measure to Assess Physical, Psychosocial, and Existential Issues in COPD Journal of Clinical Medicine ·H. Sörensen,Cecilie Lindström Egholm,Anders Løkke,Edina Nikolett Barna,Mie Sand Hougaard,Mette Raunkiær,Ingeborg Farver-Vestergaard	2024	1
2	Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients Arthritis Research & Therapy ·J. Wendler,Gerd R Burmester,H. Sörensen,Andreas Krause,Constanze Richter,Hans‐Peter Tony,Andrea Rubbert‐Roth,Peter Bartz‐Bazzanella,Siegfried Wassenberg,Iris Haug-Rost,Thomas Dörner	2014	44
3	Evaluation of a novel 7‐joint ultrasound score in daily rheumatologic practice: A pilot project Arthritis Care & Research ·M. Backhaus,Sarah Ohrndorf,H. Kellner,Johannes Strunk,Tina Backhaus,Wolfgang Hartung,Horst Sattler,Katinka Albrecht,Jörg Kaufmann,Karsten Becker,H. Sörensen,L. Meier,G.-R. Burmester,Wolfgang Schmidt	2009	318
4	Rose hip herbal remedy in patients with rheumatoid arthritis – a randomised controlled trial Phytomedicine ·Stefan N. Willich,Karin Rossnagel,Stephanie Roll,Alexandra Wagner,O Mune,J. Erlendson,A. Kharazmi,H. Sörensen,K. Winther	2009	69
5	Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis. PubMed ·Xenofon Baraliakos,Joachim Listing,Martín Rudwaleit,J. Brandt,Rieke Alten,Gerd R Burmester,Erika Gromnica‐Ihle,Hildrun Haibel,Stephan Schewe,Matthias Schneider,H. Sörensen,H. Zeidler,Sudha Visvanathan,Joachim Sieper,Juergen Braun	2007	50
6	Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical and magnetic resonance imaging data Arthritis Care & Research ·Xenofon Baraliakos,J. Brandt,Joachim Listing,Hildrun Haibel,H. Sörensen,Martín Rudwaleit,Joachim Sieper,Jürgen Braun	2005	128
7	Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years Lara D. Veeken ·Joseph M. Braun,Xenofon Baraliakos,J. Brandt,Joachim Listing,A. Zink,Rieke Alten,Gerd R Burmester,Erika Gromnica‐Ihle,H. Kellner,Matthias Schneider,H. Sörensen,H. Zeidler,Joachim Sieper	2005	150
8	Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab (vol 7, pg R439, 2005) Arthritis Research ·Xenofon Baraliakos,Joachim Listing,J. Brandt,A. Zink,Rieke Alten,Gerd R Burmester,Erika Gromnica‐Ihle,Herbert Kellner,Matthias Schneider,H. Sörensen,Hennig Zeidler,Martín Rudwaleit,Joachim Sieper,Juergen Braun	2005	9
9	Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis Annals of the Rheumatic Diseases ·Joseph M. Braun,J. Brandt,Joachim Listing,A. Zink,Rieke Alten,Gerd R Burmester,Erika Gromnica‐Ihle,H. Kellner,M Schneider,H. Sörensen,H. Zeidler,Joachim Sieper	2004	131
10	Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis Arthritis & Rheumatism ·J. Brandt,Andrei Khariouzov,Joachim Listing,Hildrun Haibel,H. Sörensen,L. Grassnickel,Martín Rudwaleit,Joachim Sieper,Jürgen Braun	2003	359
11	Long‐term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three‐month, randomized, placebo‐controlled trial Arthritis & Rheumatism ·Jonathan Braun,J. Brandt,Joachim Listing,A. Zink,Rieke Alten,Gerd R Burmester,W. Golder,Erika Gromnica‐Ihle,H. Kellner,Matthias Schneider,H. Sörensen,H. Zeidler,Jaqueline Reddig,Joachim Sieper	2003	192
12	The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five‐year followup study Arthritis & Rheumatism ·Joachim R. Kalden,M Schattenkirchner,H. Sörensen,Paul Emery,Chris Deighton,Blaž Rozman,FC Breedveld	2003	90
13	Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trialbreakdown → The Lancet ·Jürgen Braun,J. Brandt,Joachim Listing,A. Zink,Rieke Alten,W. Golder,E Gromnica-lhle,H. Kellner,Andreas Krause,Matthias Schneider,H. Sörensen,H. Zeidler,Wolfgang Thriene,Joachim Sieper	2002	953
14	Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis Annals of the Rheumatic Diseases ·C. Fendler,S Laitko,H. Sörensen,C Gripenberg-Lerche,A Groh,J Uksila,Kaisa Granfors,Jürgen Braun,J. Sieper	2001	78
15	Therapie der ankylosierenden Spondylitis (AS) mit Radiumchlorid ( 224 SpondylAT®) Zeitschrift für Rheumatologie ·Jürgen Braun,E.‐M. Lemmel,Bernhard Manger,R. Rau,H. Sörensen,Joachim Sieper	2001	14
16	Die Radiosynoviorthese im Behandlungsplan chronisch-entzündlicher Gelenkerkrankungen Zeitschrift für Rheumatologie ·A. N. Savaser,Karl‐Titus Hoffmann,H. Sörensen,D. Banzer	1999	11
17	Differential surface expression of HLA-DRB1 and HLA-DRB4 among peripheral blood cells of DR4 positive individuals Human Immunology ·Grit Czerwony,Rieke Alten,Erika Gromnica‐Ihle,Dorothee Hagemann,Uwe Reuter,H. Sörensen,Brigitte Müller	1999	18
18	Oral type II collagen treatment in early rheumatoid arthritis. A double‐blind, placebo‐controlled, randomized trial Arthritis & Rheumatism ·Joachim Sieper,S. Kary,H. Sörensen,Rieke Alten,U. Eggens,W Hüge,Falk Hiepe,A Kühne,Joachim Listing,Norbert Ulbrich,Jürgen Braun,A. Zink,N Mitchison	1996	121
19	[Peroral norephedrine therapy of acute otitis media. A double-blind placebo-controlled study]. PubMed ·Meistrup-Larsen Ki,Naja Dam Mygind,J. Thomsen,H. Sörensen,S. Vesterhauge	1980	1
20	PERIPHERAL ARTERIAL EMBOLISM AND EMBOLECTOMY IN OLD AGE Journal of the American Geriatrics Society ·B. LYAGER NIELSEN,P. BUNDGAARD SØHOLT,H. Sörensen	1967	3

About H. Sörensen

H. Sörensen is a scholar working on Rheumatology, Hematology and Internal Medicine, having authored 25 papers that have together received 2.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (16 papers), Spondyloarthritis Studies and Treatments (14 papers), Autoimmune and Inflammatory Disorders Research (5 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Respiratory and Cough-Related Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Dupuytren's Contracture and Treatments (2 papers). The work is most often cited by research in Rheumatology (2.4k citations), Hematology (948 citations) and Immunology (1.1k citations). H. Sörensen has collaborated with scholars based in Germany, Denmark and United States. Frequent co-authors include Joachim Sieper, Joachim Listing, J. Brandt, Jürgen Braun, H. Kellner, Rieke Alten, A. Zink, H. Zeidler, Matthias Schneider and W. Golder. Their work appears in journals such as The Lancet, Journal of the American Geriatrics Society and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact